Search
Now showing items 1-1 of 1
Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer - the NEONAX trial (AIO-PAK-0313), a prospective, randomized, controlled, phase II study of the AIO pancreatic cancer group
Ettrich, Thomas J. et al. (2018)
Wissenschaftlicher Artikel